These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

46 related items for PubMed ID: 667280

  • 1. Action of somatostatin, levodopa and pyridoxine on growth hormone (GH) secretion in newborn infants.
    Delitala G, Meloni T, Masala A, Alagna S, Devilla L, Costa R.
    Biomedicine; 1978 Feb; 29(1):13-5. PubMed ID: 667280
    [Abstract] [Full Text] [Related]

  • 2. Dissociation of growth hormone and prolactin response to levodopa during pyridoxine administration.
    Delitala G, Masala A.
    Biomedicine; 1977 Jul; 27(6):219-22. PubMed ID: 20170
    [Abstract] [Full Text] [Related]

  • 3. Direct effects of catecholamines, thyrotropin-releasing hormone, and somatostatin on growth hormone and prolactin secretion from adenomatous and nonadenomatous human pituitary cells in culture.
    Ishibashi M, Yamaji T.
    J Clin Invest; 1984 Jan; 73(1):66-78. PubMed ID: 6140273
    [Abstract] [Full Text] [Related]

  • 4. Inhibition of L-dopa-induced growth hormone stimulation by pyridoxine and chlorpromazine.
    Mims RB, Scott CL, Modebe O, Bethune JE.
    J Clin Endocrinol Metab; 1975 Feb; 40(2):256-9. PubMed ID: 1117978
    [Abstract] [Full Text] [Related]

  • 5. Endurance exercise modulates levodopa induced growth hormone release in patients with Parkinson's disease.
    Müller T, Welnic J, Woitalla D, Muhlack S.
    Neurosci Lett; 2007 Jul 11; 422(2):119-22. PubMed ID: 17590511
    [Abstract] [Full Text] [Related]

  • 6. Growth hormone secretion in aging. Effect of pyridostigmine on growth hormone responsiveness to growth hormone-releasing hormone.
    Giusti M, Marini G, Sessarego P, Peluffo F, Valenti S, Caratti C, Giordano G.
    Recenti Prog Med; 1991 Dec 11; 82(12):665-8. PubMed ID: 1815302
    [Abstract] [Full Text] [Related]

  • 7. The effect of somatostatin on the rise of growth hormone and glucagon secretion induced by arginine and L-dopa in diabetic patients.
    Hansen AP, Christensen SE, Lundbaek K.
    Scand J Clin Lab Invest; 1975 May 11; 35(3):205-10. PubMed ID: 1153917
    [Abstract] [Full Text] [Related]

  • 8. Suppression of pimozide-induced prolactin secretion by piridoxine (vitamin B6).
    Delitala G, Masala A, Alagna S.
    Biomedicine; 1977 Jul 11; 27(5):191-2. PubMed ID: 562688
    [Abstract] [Full Text] [Related]

  • 9. Inhibition by somatostatin of the release of growth hormone induced by lysine-vasopressin in normal subjects.
    Chiodera P, Coiro V.
    Biomed Pharmacother; 1985 Jul 11; 39(6):334-7. PubMed ID: 2867793
    [Abstract] [Full Text] [Related]

  • 10. Effects of somatostatin in parkinsonism, growth hormone, and dopa metabolism.
    Papavasiliou PS, Cotzias GC, Rubin JI, Rosal VL, Wang YY.
    Trans Am Neurol Assoc; 1977 Jul 11; 102():90-3. PubMed ID: 616124
    [No Abstract] [Full Text] [Related]

  • 11. [Aspects of the hypothalamo-hypophyseal function in children].
    Tonini G, Tecilazich D, Bertoli G, Di Giacomo BE, Mangiarotti Marchi MA, Nordio S.
    Minerva Med; 1979 Jun 16; 70(28):1997-2006. PubMed ID: 377142
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Effects of oral administration of L-dopa on the secretion of plasma growth hormone in subjects of pediatric age].
    Rigillo N, Dammacco F, Pentasuglia N, Zimbalatti F.
    Minerva Pediatr; 1975 Apr 28; 27(15):908-14. PubMed ID: 1134455
    [No Abstract] [Full Text] [Related]

  • 14. [Role of somatostatin in the regulation of GH in rats (author's transl)].
    Wakabayashi I.
    Horumon To Rinsho; 1979 May 28; 27(5):465-71. PubMed ID: 455755
    [No Abstract] [Full Text] [Related]

  • 15. [Growth hormone secretion and somatostatin].
    Wakabayashi K, Miki N, Miyazawa Y, Kanda K, Koezuka N.
    Horumon To Rinsho; 1978 Jun 28; 26(6):524-8. PubMed ID: 688653
    [No Abstract] [Full Text] [Related]

  • 16. Effect of pimozide on levodopa-induced growth hormone release in man.
    Masala A, Delitala G, Alagna S, Devilla L.
    Clin Endocrinol (Oxf); 1977 Sep 28; 7(3):253-6. PubMed ID: 908155
    [Abstract] [Full Text] [Related]

  • 17. [Effect of somatostatin in patients with high plasma growth hormone].
    Pertzelan A, Doron M, Assa S, Keret R, Laron Z.
    Harefuah; 1977 Aug 28; 93(3-4):74-6. PubMed ID: 914113
    [No Abstract] [Full Text] [Related]

  • 18. Effect of medroxyprogesterone acetate on the sleep induced peak of growth hormone secretion.
    Lucke C, Glick SM.
    J Clin Endocrinol Metab; 1971 Nov 28; 33(5):851-3. PubMed ID: 4942160
    [No Abstract] [Full Text] [Related]

  • 19. [Function of the hypothalamo-hypophyseal axis in infants with chronic raised intracranial pressure assayed by means of growth hormone secretion following insulin stimulation].
    Krauze M, Stankiewicz J, Surowiec-Gielas A, Zebala J.
    Pol Tyg Lek; 1979 Jan 15; 34(3):93-6. PubMed ID: 424344
    [No Abstract] [Full Text] [Related]

  • 20. [Inhibition of growth-hormone release in man: comparative study between somatostatin-14 and -28 (author's transl)].
    Pradayrol L, Bommelaer G, Fourmy D, Fagot-Revurat P, Rozental G, Essaid A, Bouisson M, Wünsch E, Ribet A.
    Gastroenterol Clin Biol; 1982 Feb 15; 6(2):166-9. PubMed ID: 6120876
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 3.